推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 新華社雅加達(dá)專(zhuān)電，中國(guó)福建漳州片仔癀藥業(yè)公司22日宣布，將同印度尼西亞合作伙伴三有集團(tuán)聯(lián)手斥資8000萬(wàn)美元，進(jìn)軍印尼中藥市場(chǎng)。
漳州片仔癀是蜚聲海內(nèi)外的名貴中成藥，其制作工藝、配方屬?lài)?guó)家絕密，與云南白藥、阿膠等同屬?lài)?guó)家一級(jí)保護(hù)的中藥品種。漳州片仔癀在印尼享有盛名，據(jù)片仔癀藥業(yè)公司董事長(zhǎng)劉建順介紹，片仔癀在印尼全國(guó)2500家中藥房均有銷(xiāo)售，印尼市場(chǎng)銷(xiāo)量占據(jù)片仔癀海外總銷(xiāo)量的40%。
在當(dāng)天于雅加達(dá)舉行的產(chǎn)品推介座談會(huì)暨簽約儀式上，劉建順宣布，片仔癀藥業(yè)與印尼最大中成藥進(jìn)口代理商三有藥業(yè)公司合作，將結(jié)合印尼當(dāng)?shù)爻Ｒ?jiàn)病、多發(fā)病特點(diǎn)，投資5000萬(wàn)美元建立合資企業(yè)，生產(chǎn)、銷(xiāo)售中藥、中成藥及日化品等。此外，雙方還將斥資3000萬(wàn)美元，合資建立中藥材種植、養(yǎng)殖和加工基地。
印尼藥品和食品管理局副局長(zhǎng)阿魯斯提約諾對(duì)中國(guó)中藥企業(yè)投資印尼表示感謝。他說(shuō)，印尼是世界第四人口大國(guó)，隨著經(jīng)濟(jì)的發(fā)展，印尼人民對(duì)健康的重視程度越來(lái)越高，對(duì)中藥的需求潛力巨大。片仔癀是印尼百姓家喻戶曉的藥品，“相信雙方合作必將進(jìn)一步開(kāi)拓印尼中藥市場(chǎng)”。
